TUESDAY OCTOBER, 13RD PLACE: CASINO BELLEVUE- BIARRITZ THS 9 OPENING SESSION
|
|
- Darrell Andrews
- 6 years ago
- Views:
Transcription
1 TUESDAY OCTOBER, 13RD PLACE: CASINO BELLEVUE- BIARRITZ THS 9 OPENING SESSION ROUND TABLE STORIESANDHISTORYOFA DISCOVERY : THE METHADONE ODYSSEY 5:00PM- 7:30PM Mary-Jeanne KREEK(New York) Charles O BRIEN(Philadelphie), Jean-Jacques DEGLON(Genève), Christian TREPO(Lyon), Marc AURIACOMBE(Bordeaux), Miguel CASAS (Barcelone), Jean-Pierre DAULOUEDE(Bayonne) FOLLOWING THIS DEBATE, A RECEPTION WILL BE OFFERED IN THE BELLEVUE S ROTONDE BY BIARRITZ CITY
2 9:00AM- 1:00PM WEDNESDAY OCTOBER, 14TH PLENARY SESSION Co-Chairmen: Christian TREPO(Lyon) and Charles O BRIEN(Philadelphie) Moderator: Bruno AOUIZERATE(Bordeaux) The added preventive benefit of Highly Active Antiretroviral Therapies(HAART) Julio MONTANER(Vancouver) Genomic approach to addiction treatment Charles O'BRIEN(Philadelphie) Stress Sensitivity, SNPs and Addictions Mary Jeanne KREEK(New York) BREAK Benefit of agonists in addiction therapies Miguel CASAS(Barcelone) 10 years since the report on drugs dangerousness, what about our hopes Bernard ROQUES(Paris) 1:00PM- 2:30PM POSTERS SESSION- POSTERS SESSION- POSTERS SESSION RHUNE 1 WORKSHOP 1: PAIN AND ADDICTION (Société Francophone d Addictologie) Chairman: Boyan CHRISTOPHOROV(Paris)- Moderator: Didier TOUZEAU(Bagneux) Introduction Pascal COURTY(Clermont-Ferrand) Neurobiological aspects of pain Florence NOBLE(Paris) Pain Hypersensitivity of patients under Opiate Substitution Treatments(OST) Nicolas AUTHIER(Clermont-Ferrand) Undefined title Vincent BOUNES(Toulouse) Pain and surgical intervention in patients under OST Christian DUALE(Clermont-Ferrand) WORKSHOP 2: THE VIRUS, INTIMATE ENEMY (Satellite Symposium sponsored by Roche laboratories) Moderators: Catherine CHEVALIER(Limoges) and Pascal MELIN(Saint Dizier) Improvment of HCV screening thanks to capillary microsampling Martine BIDAUD(Poitiers) HCV and therapeutic education: the successful experience of the Villejuif hospital Sylvie HILLON(Villejuif) HCV: to a better care access by managing psychiatric disorders Jean-Philippe LANG(Erstein) Influenza, lies, all and anything! Jean-Marie COHEN(Paris) WORKSHOP 3: EPIGENETICS AND GENETICS Chairman: Charles O BRIEN(Philadelphie) Moderator: Amine BENYAMINA(Villejuif) Pharmacogenetics in alcoholism Philip GORWOOD(Paris) Gene-environment interaction in addiction Alain MALAFOSSE(Genève)
3 VAGUES 3+4 RHUNE 2 WEDNESDAY OCTOBER, 14TH WORKSHOP 4: FROM HARM REDUCTION TO HEALTH EDUCATION... Moderator: Fabrice OLIVET(Paris) The requirement threshold: an ambiguous concept Elisabeth AVRIL(Paris) From education to information sharing, from festive to urban place Valère ROGISSARD(Paris) From the Montpellier s consumption room to the 19th may consumption room Pierre CHAPPARD(Paris) WORKSHOP 5: GAMES AND ADDICTIONS Chairman: Jean-Luc VENISSE(Nantes) Preventive approach of gambling from 2 studies Isabelle GIROUX(Québec) Video games and addiction? Elisabeth ROSSE(Paris) Adolescents, games and other risky behaviors Marie BRONNEC(Nantes) 4:30PM- 5:00PM RHUNE 1 BREAK WORKSHOP 1: ALCOHOL AND CANNABIS Moderator: Amine BENYAMINA(Villejuif) HCV, Cannabis and fibrosis Bertrand LEBEAU(Paris) Therapeutic cannabis Martin BARRIUSO(Bilbao) Clinical experience with Baclofen in general pratice Bernard JOUSSAUME(Bandol) 5:00PM- 7:00PM WORKSHOP 2: ADOLESCENTS AND ADDICTIONS Moderator: Emmanuelle PEYRET(Paris) Links between substance abuse and violence in adolescents in psychiatric and school places Grégory MICHEL(Bordeaux) Pharmacological therapeutic in Attention Deficit and Hyperactivity Disorder (ADHD) and alkaloid addiction Eric KONOFAL(Paris) Early Diagnosis of dependence vulnerability by diagnosing cyberdependence in children and adolescents, identification of vulnerability factors and coverage Emmanuelle PEYRET(Clamart) WORKSHOP 3: ADDICTION, PREGNANCY AND PARENTHOOD Co-Chairmen: Gabriele FISCHER(Vienne) and Claude LEJEUNE(Paris) Moderator: Laurent GOURARIER(Paris) Progress over the last decade in treatment of opioid dependent women and their neonates Gabriele FISCHER(Vienne) Crack baby: Broken? About cocaine and perinatality in 2009 in France. Claude LEJEUNE(Paris) Medically Assisted Procreation, maternity and addiction Maïca REICHERT(Strasbourg) et Michèle WEIL(Strasbourg) RHUNE 2 VAGUES 3+4 WORKSHOP 4: PSYCHIATRY AND HCV Moderators: Pascal MELIN(Saint Dizier) and Laurent MICHEL(Limeil Brevane) It saboutaguywhowondersifhe sdepressed Patrick FAVREL The HEPA-VIH study and psychiatric symptoms Laurent MICHEL(Limeil Brevane) Hyper-emotionality during Hepatitis C diagnosis and care. Jean-Philippe LANG(Erstein) Benefits of an individual psychiatric/psychologic care Marc SCHOEFFLER(Erstein) From the PEGAPSY survey to the Lazard syndrome Pascal MELIN(Saint Dizier) WORKSHOP 5: OUTREACH, GOING TO THE FRONT! Moderator: Anne COPPEL(Paris)- Speaker: Malika TAGOUNIT(Paris)
4 9:00AM- 11:00AM THURSDAY OCTOBER, 15TH PLENARY SESSION Co-Chairmen: Jean-Jacques DEGLON(Genève) and Aimé CHARLES NICOLAS(Fort de France) Adolescence, body image, anabolic steroids and drugs polyconsumption: myth or reality? Victor AGULLO(Valencia) Abuse liability of maintenance medications for opioid Sandra COMER(New York) The Contradictions and Complementarities between Law Enforcement and Health: An Ethnographic Perspective from the U.S. Inner City Philippe BOURGOIS(Philadelphie) Review of the scientific evaluation of Insite, North America's first medically-supervised injection facility(sif) Michael John MILLOY(Vancouver) PLENARY SESSION Co-Chairmen: Jacques NORMAND(Bethesda) and Marc AURIACOMBE(Bordeaux) Moderator: Patrizia CARRIERI(Marseille) 11:00AM- 1:00PM 1:00PM- 2:30PM Drug Treatment as HIV Prevention: Expanding Options for Communities David METZGER(Philadelphie) Treatment of heroin addiction and outcomes for injection risk behaviors Michael GOSSOP(Londres) Buprenorphine and methadone maintenance in jail and post release Andrew ROSENBLUM(New York) Opiate Substitution Treatment in Australia Adrian DUNLOP(Newcastle) POSTERS SESSION- POSTERS SESSION- POSTERS SESSION VAGUES 3+4 WORKSHOP 1: A NEW THERAPEUTIC: ORAL HEROIN Chairman: Joan COLOM(Barcelone) Co-Chairman: Celina PEREDA(Vitoria Gazteiz) Moderator: Miguel CASAS(Barcelone) Speakers: Gerrit VAN SANTEN(Amsterdam), Ulrich FRICK(Carinthia) Joan Carles MARCH(Grenade), Miguel CASAS(Barcelone) WORKSHOP 2: THERAPEUTIC COMMUNITIES Moderator: Marc AURIACOMBE(Bordeaux) Speaker: Luis PATRICIO(Lisbonne) RHUNE 1 WORKSHOP 3: HEPATITIS C VIRUS (Satellite Symposium sponsored by Schering-Plough laboratories) Addictions and dual disorders in drug users Cyrille ORIZET(Paris) Screening of addictive disorders and urinary follow up of drug users Abdelghani BOUSSAIRI(Saint Denis) Felt and perceptions of patients during the screenings course Michel BONJOUR(Paris) From virological to fibrosis screening Pascal MELIN(St Dizier)
5 THURSDAY OCTOBER, 15TH WORKSHOP 4: ROUGH CASES OF HARM REDUCTION CENTERS(CAARUD) Moderators: Pascal COURTY(Clermont Ferrand) and Gérard PONSARD(Charleville) The drug users from fields. Experience of the YOZ SOS Hépatites CAARUD CAARUD in Charleville Gérard PONSARD(Charleville) Breakingup:theLyoncity experience,drugaddictinacity Christine DERIS(Lyon) Thought, history and becoming of harm reduction centers Martine LACOSTE(Toulouse) Isthereaplacefora«newspirit»inCAARUD? Pascal DUFEUTREL(Le Puy en Velay) Datas of STUDY TOX survey Pascal COURTY(Clermont Ferrand) RHUNE 2 WORKSHOP 5: PRATIQUES INNOVANTES DANS LE CHAMP DES ADDICTIONS ET DES COMORBIDITES INFECTIEUSES Chairman: Georges-Henri MELENOTTE(Stasbourg) Moderator: Xavier AKNINE(Bondy) Medical microstructures, their device and their work Georges-Henri MELENOTTE(Strasbourg) and François BRUN(Marseille) Mobile intervention team(emi) Alain BARBOSA(Genève) Mini Proximity networks in Seine Saint Denis Sibel BILAL(Paris) and Philippe GRUMBERG(Gagny) 4:30PM- 5:00PM 5:00PM- 7:00PM BREAK DEBATE (not confirmed before printing) FOLLOWED BY THE CONGRESS DINNER BASKFEASTATTHEINHARRIAFARMINSAINTPÉESURNIVELLE (Route by bus)
6 FRIDAY OCTOBER, 16TH PLENARY SESSION Co-Chairmen: Jacques NORMAND(Bethesda) and Daniel ZULAIKA(San Sebastian) 9:00AM- 11:00AM HIV, HCV, Addictions and the brain Igor GRANT(San Diego) Fast HIV tests in pharmacies Daniel ZULAIKA(San Sebastian) WhathavewelearnfromAIDS,What slefttodo? Pascal MELIN(Saint Dizier) Hepatitis C: news therapeutics in 2010 Victor de LEDINGHEN(Bordeaux) 11:00AM- 1:00PM PLENARY SESSION: ADDICTION AND DUAL DIAGNOSIS Co-Chairmen: Jean TIGNOL(Bordeaux) and Icro MAREMMANI(Pise) Addiction and psychosis Isabelle GOTHUEY(Ginebra) Addiction and depression Marta TORRENS(Barcelone) Addiction and ADHD José MARTINEZ RAGA(Valence) Efficacy of methadone and buprenorphine on psychopathological symptoms Icro MAREMMANI(Pise) 1:00PM- 2:30PM RHUNE 2 POSTERS SESSION- POSTERS SESSION- POSTERS SESSION WORKSHOP 1: HEPATITIS C VIRUS Moderator: Philippe CHOSSEGROS(Lyon) Needle exchanges and pharmacies Nicolas BONNET(Paris) Problem of blood access in drug users Damien LUCIDARME(Lille) Advanced coverage of liver diseases in drug users J. FOUCHER(Bordeaux) ScreeningandtreatmentofhepatitisCbythenetworkofthe medical microstructures in Alsacian drug users F. FIORANT DI NINO(Strasbourg) Benefit of an addiction center integrated into a service of hepatology F. BUHATIER(Lyon) Benefit for public health of primoprescription of HVC treatment by general practitioners Xavier AKNINE(Bondy) WORKSHOP 2: ADDICTION AND PRISONS Co-Chairmen: Gabriel MOUESCA(Bayonne) and François BES(Paris) Moderator: Saadia YAKOUB(Paris) Outgoing from jail: after 60 years, Emmaüs continues to get involved Gabriel MOUESCA(Bayonne) --->
7 ---> FRIDAY OCTOBER, 16TH Non invasive screening: HCV study with the blotter method Fadi MEROUEH(Villeneuve les Maguelone) Epidemiological assessment in prison Jean-Noël MARZO(Paris) Equivalency of cares in and outside? François BES(Paris) Tracks to improve health care of incarcerated people Sandra ESSID(Paris) RHUNE 1 WORKSHOP 3: TOBACCO AND CANNABIS (Société Française de Tabacologie) Moderator: Didier TOUZEAU(Bagneux) Introduction: issues of a multidisciplinary approach and cooperation Didier TOUZEAU(Bagneux) Treatment of pregnant addicted women: why not tobacco? Nathalie WIRTH(Nancy) Young cannabis smokers: characteristics of patients in tobacco consultation in Hendy ABDOUL(Paris) Undefined title Marion ADLER (Paris) WORKSHOP 4: RECENT DEVELOPMENTS ABOUT COCAÏNE ADDICTION Chairman: Aimé CHARLES-NICOLAS(Fort de France) In and outcomes of cocaïne Béatrice DE MONTJOYE(Paris) Strong and weak points of cocaine addiction therapeutics in Spain José PEREZ DE LOS COBOS(Barcelone) Treatment of cocaine addiction with caramelos in Bolivia Jorge HURTADO GUMUCIO(La Paz) Alcohol and Cocaïne Jérôme LACOSTE(Fort de France) VAGUES 3+4 WORKSHOP 5: NEW TECHNOLOGIES PRESENTATION: DROJNET Chairman: Juan DEL POZO(Logrono) New technologies of information and communication in the field of addiction prevention: Drojnet Project Laura PEREZ(Logrono) Benefit of DROJNET Project in the field of harm reduction in festive place Jean-Pierre DAULOUEDE(Bayonne) Use of new technologies of information and communication(ntic) in the field of prevention and harm reduction in addictions The Aragon Experience: Ana Isabel NAVARRO(Zaragoza) The Catalan Experience: Joan COLOM(Barcelona) 4:30PM- 5:00PM 5:00PM- 6:00PM PAUSE CLOSING SESSION
8
Place of addiction-informed comprehensive treatment in HIV care
Place of addiction-informed comprehensive treatment in HIV care Cecile Denis, PhD Center for Studies of Addiction, University of Pennsylvania, Philadelphia, USA University of Bordeaux, Bordeaux, France
More informationManaging drug misuse in pregnancy and beyond
Managing drug misuse in pregnancy and beyond Dr Emily Finch Clinical Director Addictions CAG, South London and Maudsley Foundation NHS Trust Rachel Evans, Adfam 1 / Aims of the session Update on management
More informationFirst results collected by Argos, DCR in Strasbourg opened in november 2016
Photo Marine Saiah First results collected by Argos, DCR in Strasbourg opened in november 2016 Danièle BADER, Leader of Ithaque Association EMCDDA, DRID Meeting 18-20 september 2017 A crossborder experimentation
More informationThe Pillars Approach: A Case Study
The Pillars Approach: A Case Study Dorothy J. Chaney, M.Ed. CADCA Trainer www.cadca.org Building Safe, Healthy, and Drug Free Communities Learning Objectives Discover how the pillars approach utilizes
More informationLegend. Innovations in Treatment and Recovery. Industry Symposia Oral Communications E Short Communications SUNDAY FEBRUARY 25, 2018
Legend Plenary Innovations in Neuroscience Innovations in Treatment and Recovery Innovations in Thinking Innovations in Technologies Innovations in Policy and Planning Health Industry Symposia Oral Communications
More informationORGANIZATION OF AMERICAN STATES
ORGANIZATION OF AMERICAN STATES INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION FIRST INTER-REGIONAL FORUM OF EU-LAC CITIES: PUBLIC POLICIES IN DRUG TREATMENT April 2 5, 2008 Santo Domingo, Dominican Republic
More informationEuropean drugs summer school 2018
FINAL PROGRAMME European drugs summer school 2018 Illicit drugs in Europe: demand, supply and public policies 25 June 6 July 2018, Lisbon In collaboration with I Week 1 Monday 25 June 2018 10.00 10.30
More informationPublic drug policies Catalonia
Public drug policies Catalonia Public Health Agency of Catalonia Xavier Majó Roca Catalonia Barcelona Territory: 32.000 km2 Population: 7.523.000 M Own language and culture 1. What s happened in Catalonia
More informationHIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015
HIV/AIDS Think Tank meeting: EMCDDA report Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015 European Drug Report 2015 Drop o Trends in seizures by substance from 2009 o Drug and related long-term
More informationSubstance use and misuse
An open learning programme for pharmacists and pharmacy technicians Substance use and misuse Educational solutions for the NHS pharmacy workforce DLP 160 Contents iii About CPPE open learning programmes
More informationOST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success
XVIII International AIDS Conference, 2010 Vienna UNODC-GTZ Satellite Symposium: OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success Joerg
More informationModels of good practice in drug treatment in Europe. Project group
Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008
More informationMethadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies
Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies Wendee Wechsberg, PhD, Senior Director Substance Abuse Treatment Evaluations and Interventions
More informationOrganized by. Scientific comittee
July 11 & 12, 2019 Institut Pasteur Organized by Arun Sanyal Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA Lawrence Serfaty Hôpital Hautepierre Hôpitaux Universitaires de
More information1 st course Genome Instability & Human Disease - May
1 st course Genome Instability & Human Disease - May 9-13 2016 A Training Unit International Course - Open conferences (in blue) Monday, May 9 th 09:45 Training Unit Institut Curie Sarah Lambert & Aura
More informationEVATEL Study. Remote follow-up of patients implanted with an ICD The prospective randomized EVATEL study
EVATEL Study Remote follow-up of patients implanted with an ICD The prospective randomized EVATEL study Philippe Mabo, Pascal Defaye, Nicolas Sadoul, Jean Marc Davy, Jean-Claude Deharo, Salem Kacet, Eric
More informationAn Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women
An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women Michelle Tuten, Ph.D. Assistant Professor Department of Psychiatry and Behavioral Sciences and Johns
More informationAcademic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD
Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse Pain, Pain Management and the Opioid Epidemic Symposium Jill M Williams, MD Professor Psychiatry Director, Division Addiction
More informationNew Jersey Mental Health and Addiction Providers Meeting April 26, Shereef Elnahal, M.D., M.B.A. Commissioner New Jersey Department of Health
New Jersey Mental Health and Addiction Providers Meeting April 26, 2018 Shereef Elnahal, M.D., M.B.A. Commissioner New Jersey Department of Health DOH Healthcare & Public Health Priorities Reduce disparities
More informationThe forgotten group: a new HIV outbreak amongst people who inject drugs. Patricia Anderson Lead CNS BBV Brownlee Centre
The forgotten group: a new HIV outbreak amongst people who inject drugs Patricia Anderson Lead CNS BBV Brownlee Centre No conflicts to declare Potted History 1981 Modern wave of drug misuse Glasgow soared
More informationFirst Scientific Symposium Translational Research in Alzheimer. Paris - September 18, 2009 Collège de France
First Scientific Symposium Translational Research in Alzheimer Paris - September 18, 2009 Collège de France 8h30 Welcome coffee 9h-9h30 Opening remarks - Philippe Lagayette, President of French National
More informationGLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy
GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.
More informationCours Pasteur. Molecular Cancer Genetics. September 18-29, 2017
Cours Pasteur Molecular Cancer Genetics September 18-29, 2017 Directors François CLEMENT-BIDARD Co-director, Institut Curie Hospital Jean-Pierre VARTANIAN Co-director, Institut Pasteur PROGRAM 2017-2018
More informationSigns of success latest national NESI data?
Needle Exchange Surveillance Initiative Signs of success latest national NESI data? Alison Munro (University of the West of Scotland) Study partners Professor Avril Taylor Chief Investigator (UWS) Dr Alison
More informationHIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014
More informationBrief History of Methadone Maintenance Treatment
METHADONE Brief History of Methadone Maintenance Treatment Methadone maintenance treatment was on the cusp of the social revolution in the sixties. Doctors and public health workers had concluded what
More informationHighlight underserved for screening, prevention and treatment of viral hepatitis B and C in Europe Ljubljana, Slovenia March 2016
Highlight underserved for screening, prevention and treatment of viral hepatitis B and C in Europe Ljubljana, Slovenia 10-11 March 2016 Innovative community-based educational face-to-face intervention
More informationVersion 1.11 of 20/07/2018
Version 1.11 of 20/07/2018 NICE JANUARY 17-19, 2019 6 th International Workshop on Lung Health New approaches to respiratory diseases PRESIDENTS: F. BLASI, G.W. CANONICA CHAIRMEN: S. CENTANNI, J.C. VIRCHOW,
More informationJuly 5 & 6, 2018, Paris SCIENTIFIC PROGRAM
www.paris-nash.org Dear Colleagues, We are delighted to announce the 4th Paris NASH Meeting to be held on July 5-6 th 2018. This international academic meeting is aimed to do a deep-dive into many aspects
More informationChad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next
Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery Drug Policy, Harm Reduction, and What s Next The start or lack thereof of Drug Policy in the United States The Harrison Narcotics
More informationJust Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health
Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health March 12, 2018 Envisioning a socially just system where all New Yorkers
More informationSouth Asian Cocktail The Predominant Drug Use Pattern in Nepal and its Association with Spread of HIV
14 Original Article South Asian Cocktail The Predominant Drug Use Pattern in Nepal and its Association with Spread of HIV Ojha S P 1, Sigdel S 2, H-G M 3, Verthein U 4 1 Tribhuvan University Teaching Hospital,
More informationHarm reduction among drug users in Spain
Harm reduction among drug users in Spain Luxemburg,, 27 October 21 Dr. José Manuel Arroyo Cobo Deputy Director General of Health in Prisons Ministry of Internal Affairs Dr. Tomás s Hernández ndez Fernández
More informationMagnitude. SELECT A TOPIC...
Page 1 of 6 SELECT A TOPIC..... NIDA Home > Drug Abuse and Addiction: One of America's Most Challenging Public Health Problems Magnitude Drug Abuse is Costly Drug abuse is a major public health problem
More informationResidual Cancer. May 3-5, International Symposium. on Minimal. Le Corum. > Preliminary. Program MONTPELLIER, FRANCE
International Symposium th on Minimal Residual Cancer > Preliminary Program May 3-5, 2018 Le Corum MONTPELLIER, FRANCE Organizers: www.ismrc2018.com > Committee & Speakers > Welcome to Montpellier Scientific
More informationOpioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity
Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity Holly Hills, Ph.D. June 13, 2017 Department of Mental Health Law and Policy Overview: Persons who have not been in
More informationOPIOID SUBSTITUTION THERAPY RISKS & BENEFITS
OPIOID SUBSTITUTION THERAPY RISKS & BENEFITS LEO O. LANOIE, MD, MPH, FCFP, CCSAM, ABAM, FISAM, MRO Dr. Leo Lanoie, 2017 DISCLAIMER In the past year I have accepted funds from Purdue for speaking OPIOID
More informationAlberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007
Alberta Alcohol and Drug Abuse Commission POSITION ON ADDICTION AND MENTAL HEALTH POSITION The Alberta Alcohol and Drug Abuse Commission (AADAC) recognizes that among clients with addiction problems, there
More informationClinical trials (1) Bill Friedewald. 12h : Lunch 12h : Lunch 12h : Lunch 12h : Lunch 12h : Lunch 14h
French School of Public Health Ecole des Hautes Etudes en Santé Publique Master of Public Health - Semester 3 Weeks 37 to 41: from Tuesday 8 th September to 6 th October 2009 Module Code 203, Core curriculum,
More informationNational Conference of State Legislators
National Conference of State Legislators Mark W. Parrino, M.P.A. Monday, July 20, 2009 Philadelphia, PA Medication Assisted Treatment for Opiate Addiction In the Criminal Justice System Updated August
More informationThirty years of harm reduction in the Netherlands HCV elimination ahead?
Thirty years of harm reduction in the Netherlands HCV elimination ahead? Esther Croes, MD PhD Confession 30 years 3 topics: drug use, harm reduction, HCV in 15 minutes IT DOESN T FIT!! 2 Disclosure Esther
More informationDISCLOSURE ESPACE GAIA, FIRST DCR IN PARIS SINCE OCTOBER /06/2017
ESPACE GAIA, FIRST DCR IN PARIS SINCE OCTOBER 2016 First results and perspectives DISCLOSURE DR Elisabeth AVRIL Presentation : Espace GAIA, first DCR in Paris : first results and perspectives Mundipharma,
More informationPharmacokinetic, Safety and Efficacy of Darunavir/Ritonavir in HIV+ Pregnant Women
Pharmacokinetic, Safety and Efficacy of Darunavir/Ritonavir in HIV+ Pregnant Women DR MINH LÊ PHARMACO-TOXICOLOGY DEPARTMENT APHP, HÔPITAL BICHAT-CLAUDE BERNARD PARIS, FRANCE ABSTRACT #O_01 17TH INTERNATIONAL
More informationHHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder
HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder Brett Giroir, U.S. Department of Health and Human Services Join the conversation at #OUDTreatment #EndTheStigma Expanding
More informationTable of Contents VOLUME 1
VOLUME 1 A Accidents and Injuries from Alcohol... 1 Accidents and Injuries from Drugs..... 4 Addiction: Concepts and Definitions... 7 Addictive Personality............... 12 Adolescents, Drug and Alcohol
More information201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone.
201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone. RELATES TO: KRS 311.530-311.620, 311.990 STATUTORY AUTHORITY: KRS
More informationDrug demand reduction and harm reduction: complementary approaches. Gilberto Gerra Chief Global Challenges Section Division for Operations
Drug demand reduction and harm reduction: complementary approaches Gilberto Gerra Chief Global Challenges Section Division for Operations The comprehensive approach: no contrast, but synergism, between
More informationScience = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse
Science = Solutions For Substance Use Disorders and Infant Outcomes Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse Science = Solutions Increased Opioid Mortality: Greater
More informationWhat is harm reduction?
What is harm reduction? The International Harm Reduction Association (IHRA) defines harm reduction as the policies, programmes and practices that aim to reduce the harms associated with the use of psychoactive
More informationNHS FORTH VALLEY LOCAL ENHANCED SERVICE (2010) General Practitioner Prescribing Service (GPPS) Opiate Assisted Treatment Service Specification
NHS FORTH VALLEY LOCAL ENHANCED SERVICE (2010) Rationale General Practitioner Prescribing Service (GPPS) Opiate Assisted Treatment Service Specification Aims It is the responsibility of general practitioners
More informationNORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Opioid Use Disorders Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 Opioid Use Disorders Importance of opioid use disorders Screening and
More informationOpioid Use Disorders and Pregnancy. Marcela Smid, MD Maternal-Fetal Medicine
Opioid Use Disorders and Pregnancy Marcela Smid, MD Maternal-Fetal Medicine UNIVERSITY OF UTAH HEALTH, 2017 OBJECTIVES Definitions Epidemiology Pharmacology Effects on pregnancy Screening Treatment CARE
More informationU.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs
U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and
More informationFrench Networks for Sarcoma and GIST. O Mir, JY Blay
French Networks for Sarcoma and GIST O Mir, JY Blay Introduction Since 2009 a network of 26 reference multidisciplinary centers aiming to improve the quality of care for sarcoma patients in France was
More informationInnovations in Harm Reduction
Innovations in Harm Reduction New York Training Calendar October- December 2012 Calendar Trainings... 2 NEW Institute Training Policies... 7 Registration Form... 8 9th National Harm Reduction Conference...
More informationATLAS on substance use 2017:
WHO Forum on alcohol, drugs and addictive behaviours Enhancing public health actions through partnerships and collaboration ATLAS on substance use 17: resources for the prevention and treatment of substance
More information1st Iberoamerican Congress of Neuropsychology. June 1-4, 2016, 2016 at the Bilbao Exhibition Centre - BEC
WEDNESDAY, JUNE 1 8:30-9:00 Registration Pre-conference workshops 1. Pre-conference workshops 2. Pre-conference workshops 3. Pre-conference workshops 4. 9:00-12:00 Analysis and uses of fmri in Neuropsychology
More informationPsychiatric Comorbidities I
Psychiatric Comorbidities I Psychiatric comorbidities were clinically detected in 67% of all evaluable patients, of them: Of them the most frequent disorders were: anxiety (53%) mood (48%) sleep (41%)
More informationJohann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works
From the street to the NICU Richard Christensen, PA, CAS Johann Hari Treatment works Truths Disconnect with pregnant women seeking treatment Disconnect between community and science Medication is not a
More informationTREATING OPIOID ADDICTION IN HOMELESS POPULATIONS
TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS Challenges and Opportunities Providing Medication Assisted Treatment (Buprenorphine) August 18, 2016 SPEAKERS TODAY Nilesh Kalyanaraman, MD, Chief Health
More informationHeroin use is associated with progression to cirrhosis in HIV-HCV co-infected patients
Heroin use is associated with progression to cirrhosis in HIV-HCV co-infected patients 7 th HIV & Hepatitis Co-infection workshop Milan, June 2011 Laurence Brunet, Erica Moodie, Kathleen Rollet, Mark Tyndall,
More informationThe impact of economic recession on drug users and drug treatment
The impact of economic recession on drug users and drug treatment Designing and implementing responsive drug policies under fiscal constraints: the case of Greece Meni Malliori Assoc. Prof. of Psychiatry
More informationLYON. FRANCE NOVEMBER / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE AND CLINICAL RESEARCH
LYON. FRANCE NOVEMBER 29-30 / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE https://events.easl.eu/eventportal/ Information/MLYON2013/HOME.aspx Abstract submission deadline:
More informationPasteur course INTERNATIONAL SCHOOL OF TRANSLATIONAL PSYCHIATRY TRANS- PSY
Pasteur course INTERNATIONAL SCHOOL OF TRANSLATIONAL PSYCHIATRY TRANS- PSY PROGRAM 2017-2018 INTERNATIONAL SCHOOL OF TRANSLATIONAL PSYCHIATRY TRANS- PSY JUNE 25 th JUNE 29 th, 2018 Course directors Aroldo
More informationCROATIA. Venija Cerovecki, MD, GP. University of Zagreb School of Medicine Department for Family Medicine
CROATIA Experiences and issues in the management of drug, health and social co-morbidities among clients in opioid substitution treatment (OST) with GPs Venija Cerovecki, MD, GP University of Zagreb School
More informationThe Opioid-Exposed Woman
The Opioid-Exposed Woman Management Considerations for Labor and Delivery Jane Sublette, MS, RN, CNM, WHNP-BC Fairview Ridges Hospital Objectives Describe opioid-associated risks to the mother and fetus
More informationThe Organizing Committee
Designed by Mar Abril On behalf of the International Society of Chocolate and Cocoa in Medicine (ISCHOM), it is a great pleasure to announce the second International Congress on Chocolate and Cocoa in
More informationAbuse Liability of Maintenance Medications for Opioid Dependence
Abuse Liability of Maintenance Medications for Opioid Dependence Sandra D Comer, PhD Professor of Clinical Neurobiology Columbia University New York State Psychiatric Institute New York, NY THS Conference
More informationwho use drugs in order to assist them in reducing harm while in the cycle of addiction
August 16, 2016 } Accepts that illicit drug use is part of our world, and chooses to minimize its harmful effects rather than ignore or condemn them } Calls for the provision of services to people who
More informationChanging Course: statewide efforts to combat the opioid epidemic in California
Changing Course: statewide efforts to combat the opioid epidemic in California Kelly Pfeifer, MD kpfeifer@chcf.org April 26, 2018 State of Reform conference STAT Special Report: 52 weeks, 52 faces Obituaries
More information9. In comparing the relative toxicity of marijuana and cocaine, it is important to take into account A. the user's gender. B. availability and price.
02 Student: 1. The Canadian government, in the early 1900s had virtually no laws regulating the sale and use of drugs. In general the government took a "hands-off" approach that has been referred to as
More informationOctober 15 & WORKSHOP ON DRUG DISCOVERY AND INFECTIOUS DISEASE. IMéRA, Maison des astronomes, Marseille
October 15 & 16 2015 WORKSHOP ON DRUG DISCOVERY AND INFECTIOUS DISEASE IMéRA, Maison des astronomes, Marseille Organizing committee Philippe HALFON Hôpital Européen, laboratoire Alphabio, service maladies
More information2018 SPA Annual Convention Program
2018 SPA Annual Convention Program Wednesday, March 14, 2018 8:00 am 5:00 pm Full-Day Workshops (2) 8:00 am 11:45 am Half-Day Morning Workshops (3) 11:45 am - 1:15 pm Lunch Break 1:15 pm 9:45 pm Full-Day/Afternoon-Evening
More informationWednesday, November 8th, 2017
ADDICTION MEDICINE SESSIONS FMF 2017 Session Number: Name: Date: Time: Description: W173 The Opioid Epidemic: How emergency physicians can help Wednesday, November 8th, 2017 10:00 12:15 Canada is in the
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D SIXTY-THIRD REGULAR SESSION April 25-27, 2018 México D.F., México OEA/Ser.L/XIV.2.63 CICAD/doc.2385/18 25 April 2018 Original: English THE OPIOID
More informationThe National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015
The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 December 21, 2015 2 December 21, 2015 3 Can we eliminate hepatitis C? Treatments December 21, 2015 4 We Have the Roadmap
More informationThe Social Worker s Role in Medication Assisted Treatment
The Social Worker s Role in Medication Assisted Treatment Rocky Ephraim Lucas, LICSW Behavioral Health Consultant, Kanawha City Health Center (Cabin Creek Health Systems) What is Medication-Assisted Treatment
More informationMaternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC
Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Objectives 1. Discuss the effects of opiate addiction on mothers and infants. 2. Discuss a Medical Home
More informationBuilding capacity for a CHC response to Ontario's Opioid Crisis
Building capacity for a CHC response to Ontario's Opioid Crisis Rob Boyd Oasis Program Director Luc Cormier, RN, MScN Community Health Nurse Sandy Hill Community Health Centre #AOHC2016 @rboyd6 @SandyHillCHC
More informationOpioid use in pregnancy and Neonatal Abstinence Syndrome
Opioid use in pregnancy and Neonatal Abstinence Syndrome Morissa Ladinsky, MD Assoc. Professor of Pediatrics Division of General Pediatrics and Adolescent Medicine UAB Objectives 1. Understand the magnitude,
More informationTennessee Tobacco Settlement Health Councils Planning Meeting. Tennessee Public Health Association September 12, 2103
Tennessee Tobacco Settlement Health Councils Planning Meeting Tennessee Public Health Association September 12, 2103 Session Objectives Identify facts regarding tobacco use and its relationship to county
More informationAt the end of this presentation participants will be able to:
Diagnosis, Care and Management of Persons with HIV/AIDS Lead Faculty: Jason Farley, PhD, MPH, ANP-BC, FAAN, AACRN Co-sponsors: REACH Initiative, National AETC (Hopkins), Mid-Atlantic AETC (Hopkins), JHU
More informationAPPLICATION FOR Page 1/8 RESIDENTIAL TREATMENT
APPLICATION FOR Page 1/8 Instructions: The following form is required to begin the application process to Stonehenge. The form should be printed and completed by hand, then faxed or mailed to Stonehenge
More informationCLINICAL PATHWAY TRACK AGENDA TUESDAY, AUGUST 23, 2016
CLINICAL PATHWAY TRACK AGENDA TUESDAY, AUGUST 23, 2016 MORNING PLENARY LECTURES: LIBERTY BALLROOM (M4) 9:00 9:15 AM Welcome and Introductions Conference Co-Chairs: Laura W. Cheever, MD, ScM; Michael S.
More informationWe are most delighted to welcome you in Paris.
10 th CardioVascular Clinical Trialists Workshop Paris, December 6 th, 2007 Board of Chairmen : Faiez ZANNAD (Nancy) Desmond JULIAN (London) Bertram PITT (Ann Arbor) David GORDON (Bethesda) Ray LIPICKY
More informationHARM REDUCTION & TREATMENT. Devin Reaves MSW
HARM REDUCTION & TREATMENT Devin Reaves MSW The mission of PAHRC is to promote the health, dignity, and human rights of individuals who use drugs and communities impacted by drug use. Recognizing that
More informationConvergence of HIV, TB, Drug Use, Hepatitis. Transforming the HIV/TB Response: Defining the next 10 years
Convergence of HIV, TB, Drug Use, Hepatitis Transforming the HIV/TB Response: Defining the next 10 years Estimated numbers of IDUs and regional prevalence of HIV in people who inject drugs, 2010 Beyrer,
More informationFUnctional Testing Underlying REvascularization The FUTURE trial
FUnctional Testing Underlying REvascularization The FUTURE trial Gilles Rioufol, François Roubille, Thibault Perret, Pascal Motreff, Denis Angoulvant, Yves Cottin, Ludovic Meunier,Nathan Mewton, Michel
More informationMethadone 6. meth : physeptone : juice WHAT & WHY? No. 6 in a series of guides to help people understand what drugs are and why people take them
WHAT & WHY? Methadone 6 meth : physeptone : juice No. 6 in a series of guides to help people understand what drugs are and why people take them SECOND EDITION What? Methadone is one of a large number
More informationAGENDA Scientific Consultation on Prevention of Drug Use and Treatment of Drug Use Disorders
In collaboration with AGENDA Scientific Consultation on Prevention of Drug Use and Treatment of Drug Use Disorders Vienna International Centre, Room C-1 08-10 December 2015 Tuesday, 08 December 2015 Time
More informationTOGETHER AGAINST GENODERMATOSES TRAINING & NETWORKING SESSION
TOGETHER AGAINST GENODERMATOSES TRAINING & NETWORKING SESSION Smallville Hotel, Beirut, Lebanon 6-7 November 2014 WELCOME MESSAGE Dear Friends and Colleagues, It is our great pleasure to invite you to
More informationREDUCING THE STIGMA OF OPIOID ADDICTION AMONG PERINATAL WOMEN. Lyn Raible, M.D., Ph.D. CMO, Aegis
REDUCING THE STIGMA OF OPIOID ADDICTION AMONG PERINATAL WOMEN Lyn Raible, M.D., Ph.D. CMO, Aegis ORGANIZATION The Opioid Crisis Breaking the Stigma Neurobiology of Opioid Addiction Treatment of Opioid
More informationMany drugs of abuse are illegal drugs. Possessing, using, buying, or selling these drugs is illegal for people of any age.
1 Chapter 12 Section 1 Objectives List six ways illegal drug use can be dangerous. State five reasons a person might try illegal drugs. Identify the reason drug abuse is especially dangerous to teens.
More informationUnder the Skin : Effective advocacy for HIV prevention in Canadian prisons
Under the Skin : Effective advocacy for HIV prevention in Canadian prisons Harm Reduction 2010 April 28, 2010 Sandra Ka Hon Chu Senior Policy Analyst Canadian HIV/AIDS Legal Network The Canadian HIV/AIDS
More informationShould buprenorphine be covered for maintenance treatment in opioid dependent persons?
Prepared by: Silvia Pregno May 13,2012 Patients: people with opioid dependence Should buprenorphine be covered for maintenance treatment in opioid dependent persons? Intervention: buprenorphine Comparison:
More informationSAN FRANCISCO SAFE INJECTION SERVICES TASK FORCE
SAN FRANCISCO SAFE INJECTION SERVICES TASK FORCE MEETING 2 JULY 21 ST, 2017 9AM-11AM 25 VAN NESS AVE RM 610 SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH AGENDA WELCOME & AGENDA REVIEW MEETING 1 FINDINGS &
More informationHIV treatment cascade and epidemiological analysis of the new HIV outbreak in injecting drug users from Luxembourg
HIV treatment cascade and epidemiological analysis of the new HIV outbreak in injecting drug users from Luxembourg Carole Devaux, PhD Infectious Diseases Research Unit Department of Infection and immunity
More informationWorking with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.
Working with People Who Use Drugs in HIV Care Settings August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings Facilitator: Liz Hall, CDPH Office of AIDS Matt Curtis,
More informationMedical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center
Medical Assisted Treatment Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Current Trends Prescription Drug Abuse/Addiction Non-medical use of prescription pain killers
More information15 & 16 January International Conference on the Management of Liver Diseases. Organised by Pr Patrick Marcellin
15 & 16 January 2018 PARIS - Palais des Congrès International Conference on the Management of Liver Diseases Organised by Pr Patrick Marcellin Organising Committee Blaise Kutala, Monelle Muntlak Hôpital
More information